ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681641 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681641; 2) Community: the network communities that were significantly associated with the response to NSC 681641; 3) Molecule: the relationships between components within communities and NSC 681641; 4) MDR: the compounds that were significantly associated with the NSC 681641.

NSC Compound Enrichment Correlation
NSC 709438 Null 0.00433056621075589 0.049685173
NSC 328410 Camptothecin Derivative 0.00567322425730621 0.66596889
NSC 606497 Camptothecin Derivative 0.00567322425730621 0.80631837
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.00567322425730621 0.18414286
NSC 674182 Null 0.00567322425730621 0.57197204
NSC 683556 Camptothecin Derivative 0.00567322425730621 0.81723523
NSC 684112 Null 0.00567322425730621 0.2652813
NSC 700363 Liposomal Annamycin 0.00567322425730621 0.59465878
NSC 701743 Null 0.00567322425730621 0.73335208
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.00567322425730621 0.64315506
Total:60  Current:10    [First] [Prev] [Next] [Last]